Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Enterprise Value (2025)

Basel Medical (BMGL) posted Enterprise Value of -$791192.0 for Q4 2025, up 66.12% sequentially from -$2.3 million in Q2 2025, and up 59.45% YoY from -$496207.1 in Q4 2024.

Analysis

Basel Medical (BMGL) Enterprise Value (2025) Analysis & Trends

Basel Medical has reported Enterprise Value for 2 years, with the latest figure at -$791192.0 in Q4 2025.

  • Quarterly Enterprise Value rose 59.45% year-over-year to -$791192.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$791192.0 (up 59.45% YoY) and the FY2025 annual result came in at -$2.3 million, down 59.1% from the prior year.
  • Enterprise Value grew to -$791192.0 in Q4 2025 per BMGL's latest filing, from -$2.3 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$791192.0 in Q4 2025 and troughed at -$2.3 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 89.47 Bn 88.46 Bn 15.19 Bn
2 Tenet Healthcare 22.09 Bn 19.92 Bn 4.45 Bn
3 Encompass Health 12.08 Bn 11.95 Bn 1.34 Bn
4 Davita 11.86 Bn 11.17 Bn 1.16 Bn
5 Universal Health Services 10.15 Bn 10.01 Bn 3.29 Bn
6 Ensign 9.93 Bn 9.61 Bn 306.24 Mn
7 Chemed 6.90 Bn 6.86 Bn 221.47 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.31 Bn 4.15 Bn 192.10 Mn
10 Basel Medical 7.33 Mn 6.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -24,107.27
Jun 30, 2025 451,152.08